Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?

Shinji Itoh, Tomoharu Yoshizumi, Masaki Mori


The most common primary cancer derived from the liver is hepatocellular carcinoma (HCC), and its incidence is increasing globally (1). Hepatic resection has been established as a safe and effective treatment in patients with HCC. However, the number of patients who develop recurrence after hepatic resection remains high (2). The body composition, which consists of the skeletal muscle mass and fat area, is an important used to determine the perioperative risk and prognosis in patients with cancer.

Article Options

Download Citation